Phase I Trial of Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-versus-host Disease
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dendritic cells; T cell replacement therapy
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 13 Jul 2021 Biomarkers information updated
- 26 Feb 2013 New trial record